Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis

[1] Kim SJ(2015)Topical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of Ophthalmology Ophthalmology 44 429-439

[2] Schoenberger SD(2017)Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo BMC Ophthalmol 36 2712-2722

[3] Thorne JE(2016)Cataract surgery and nonsteroidal antiinflammatory drugs J Cataract Refract Surg 41 2043-2048

[4] McCafferty S(2018)European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1 J Cataract Refract Surg 55 108-133

[5] Harris A(2018)Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome J Cataract Refract Surg undefined undefined-undefined

[6] Kew C(2019)Anterior chamber inflammation after cataract surgery: a randomized clinical trial comparing bromfenac 0.09% to dexamethasone 0.1% Adv Ther undefined undefined-undefined

[7] Hoffman RS(2018)Quantitative evaluation of anterior chamber inflammation after phacoemulsification in clinical trials J Cataract Refract Surg undefined undefined-undefined

[8] Braga-Mele R(2020)Measuring anterior chamber inflammation after cataract surgery: a review of the literature focusing on the correlation with cystoid macular edema Clin Ophthalmol undefined undefined-undefined

[9] Donaldson K(2005)Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop Am J Ophthalmol undefined undefined-undefined

[10] Wielders LHP(2015)Long-term analysis of IOL stability of the Lewis technique for scleral fixation Eur J Ophthalmol undefined undefined-undefined

[1] Kim SJ(2015)Topical nonsteroidal anti-inflammatory drugs and cataract surgery: a report by the American Academy of Ophthalmology Ophthalmology 44 429-439

[2] Schoenberger SD(2017)Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo BMC Ophthalmol 36 2712-2722

[3] Thorne JE(2016)Cataract surgery and nonsteroidal antiinflammatory drugs J Cataract Refract Surg 41 2043-2048

[4] McCafferty S(2018)European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1 J Cataract Refract Surg 55 108-133

[5] Harris A(2018)Bromfenac ophthalmic solution 0.09% as an adjunctive therapy to topical steroids after cataract surgery in pseudoexfoliation syndrome J Cataract Refract Surg undefined undefined-undefined

[6] Kew C(2019)Anterior chamber inflammation after cataract surgery: a randomized clinical trial comparing bromfenac 0.09% to dexamethasone 0.1% Adv Ther undefined undefined-undefined

[7] Hoffman RS(2018)Quantitative evaluation of anterior chamber inflammation after phacoemulsification in clinical trials J Cataract Refract Surg undefined undefined-undefined

[8] Braga-Mele R(2020)Measuring anterior chamber inflammation after cataract surgery: a review of the literature focusing on the correlation with cystoid macular edema Clin Ophthalmol undefined undefined-undefined

[9] Donaldson K(2005)Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop Am J Ophthalmol undefined undefined-undefined

[10] Wielders LHP(2015)Long-term analysis of IOL stability of the Lewis technique for scleral fixation Eur J Ophthalmol undefined undefined-undefined